Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03OTH
|
|||
| Former ID |
DNCL002096
|
|||
| Drug Name |
Belagenpumatucel-L
|
|||
| Synonyms |
Lucanix (TN)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25.Y] | Phase 3 | [1] | |
| Small-cell lung cancer [ICD-11: 2C25.Y] | Phase 3 | [1] | ||
| Company |
NovaRx
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00676507) Phase III Lucanix Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy. U.S. National Institutes of Health. | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 590662). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.